Eikonizo Therapeutics' Unattributed VC - II Round

Eikonizo Therapeutics raised a round of funding on May 16, 2018.

Eikonizo Therapeutics uses PET imaging early in the drug discovery process to de-risk novel targets and lead candidates, allowing the company to envision an accelerated path to drug discovery and deve…

Articles about Eikonizo Therapeutics' Unattributed VC - II Round: